DIABETES | Dr. David Kerr | Creating Equity through Technology Artwork

Keeping InSight

Keeping InSight is a healthcare podcast that will feature prominent leaders in the fields of cardiovascular disease, diabetes, and transplantation in a conversational setting with Sanofi Medical Affairs. We are starting the conversation by focusing on healthcare inequities and diving into how the healthcare community can work to overcome these disparities and provide equitable care for all patients. This podcast is intended for US health professionals only.

All Episodes

Keeping InSight

DIABETES | Dr. David Kerr | Creating Equity through Technology

June 06, 2023 • Sanofi US General Medicines Medical • Season 1 • Episode 4

Join our Medical Science Liaison co-hosts, Amulya Tatachar and Erin Moline, and expert Dr. David Kerr, MBChB DM, FRCP, Director of Digital Health at the Diabetes Technology Society. Dr. Kerr will share more about democratization and discuss the importance of empowering people with diabetes through technology. In this episode, we will continue to build our conversation on trust and add this critical aspect of addressing health disparities – equitable access to technology.

Supporting Literature

Kerr D et al. A Roadmap to an Equitable Digital Diabetes Ecosystem - Endocrine Practice. Endocrine Practice. 2023;29(3):179-184.
Kerr D et al. New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes. Endocrine Practice. 2022;28(8):811-821.
Kerr D, et al. A persisting parallel universe in diabetes care within America's capital - eClinicalMedicine. The Lancet Discovery Science.2022;43. https://doi.org/10.1016/j.eclinm.2021.101244.
Kerr D, et al. Dysglycemia in adults at risk for or living with non-insulin treated type 2 diabetes: Insights from continuous glucose monitoring - eClinicalMedicine. The Lancet Discovery Science. 2021;35. https://doi.org/10.1016/j.eclinm.2021.100853
Kerr D, et al. The northeast glucose drift: Stratification of post-breakfast dysglycemia among predominantly Hispanic/Latino adults at-risk or with type 2 diabetes - eClinicalMedicine. The Lancet Discovery Science. 2022;43. https://doi.org/10.1016/j.eclinm.2021.100853.

This program is non-promotional and sponsored by Sanofi. Presenter(s) were compensated and/or received an honorarium from Sanofi in connection with this program. This program does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources and information may be available and should be investigated.

This podcast is intended for US residents only. Sanofi does not provide medical advice, diagnosis, or treatment. The health information contained herein is provided for general educational purposes only. Your healthcare professional is the best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.